Status:
COMPLETED
Evaluation of Anti-mullerian Hormone Levels as Predictive of IVF Outcomes in Women Over 38 Years Old
Lead Sponsor:
Reproductive Medicine Associates of New Jersey
Collaborating Sponsors:
Organon
Merck Sharp & Dohme LLC
Conditions:
AMH Levels
Inhibin B Levels
Eligibility:
FEMALE
38-50 years
Brief Summary
The present study is designed to evaluate the basal serum levels of anti-mullerian hormone (AMH) and inhibin B as early predictors of ovarian response, implantation rate, and pregnancy rate in women 3...
Detailed Description
Specifics aims are: a) to describe AMH and inhibin levels on day 3 previous to ART cycle; b) to analyze the association between these hormone levels and the retrieved metaphase II oocytes quantity; c)...
Eligibility Criteria
Inclusion
- 1\. Women 38 years old or older at the time of initiating treatment
Exclusion
- Uterine disease: malformation, septum, submucosal myomas, endometrial polyps Advanced endometriosis with endometrioma (s)
- No uterus
- Single ovary
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01219387
Start Date
February 1 2006
End Date
June 1 2010
Last Update
January 23 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Reproductive Medicine Assoicates of New Jersey
Morristown, New Jersey, United States, 07960
2
Reproductive Medicine Associates of PA at Lehigh Valley
Allentown, Pennsylvania, United States, 18104